Literature DB >> 12574424

Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.

Zhi-Qi Xiong1, Weihua Qian, Katsuaki Suzuki, James O McNamara.   

Abstract

The complement system consists of >30 proteins that interact in a carefully regulated manner to destroy invading bacteria and prevent the deposition of immune complexes in normal tissue. This complex system can be activated by diverse mechanisms proceeding through distinct pathways, yet all converge on a final common pathway in which five proteins assemble into a multimolecular complex, the membrane attack complex (MAC). The MAC inserts into cell membranes to form a functional pore, resulting in ion flux and ultimately osmotic lysis. Immunohistochemical evidence of the MAC decorating neurons in cortical gray matter has been identified in multiple CNS diseases, yet the deleterious consequences, if any, of MAC deposition in the cortex of mammalian brain in vivo are unknown. Here we demonstrate that the sequential infusion of individual proteins of the membrane attack pathway (C5b6, C7, C8, and C9) into the hippocampus of awake, freely moving rats induced both behavioral and electrographic seizures as well as cytotoxicity. The onset of seizures occurred during or shortly after the infusion of C8/C9. Neither seizures nor cytotoxicity resulted from the simultaneous infusion of all five proteins premixed in vitro. The requirement for the sequential infusion of all five proteins together with the temporal relationship of seizure onset to infusions of C8/C9 implies that the MAC was formed in vivo and triggered both seizures and cytotoxicity. Deposition of the complement MAC in cortical gray matter may contribute to epileptic seizures and cell death in diverse diseases of the human brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574424      PMCID: PMC6741927     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 2.  Regulation of the complement membrane attack pathway.

Authors:  B P Morgan
Journal:  Crit Rev Immunol       Date:  1999       Impact factor: 2.214

3.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

4.  Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

Authors:  S K Singhrao; J W Neal; B P Morgan; P Gasque
Journal:  Exp Neurol       Date:  1999-10       Impact factor: 5.330

5.  Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.

Authors:  N Davoust; S Nataf; R Reiman; M V Holers; I L Campbell; S R Barnum
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.

Authors:  K D Whitney; J O McNamara
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

7.  Up-regulated production and activation of the complement system in Alzheimer's disease brain.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 8.  Therapeutic inhibition of the complement system. Y2K update.

Authors:  S S Asghar; M C Pasch
Journal:  Front Biosci       Date:  2000-09-01

9.  Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis.

Authors:  K D Whitney; P I Andrews; J O McNamara
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

10.  Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.

Authors:  Tony Wyss-Coray; Fengrong Yan; Amy Hsiu-Ti Lin; John D Lambris; Jessy J Alexander; Richard J Quigg; Eliezer Masliah
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

View more
  37 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

Review 2.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

Review 3.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

Review 4.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

Review 5.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

6.  Innate immunity and inflammation in temporal lobe epilepsy: new emphasis on the role of complement activation.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

7.  Peripherally restricted viral challenge elevates extracellular glutamate and enhances synaptic transmission in the hippocampus.

Authors:  Holly C Hunsberger; Desheng Wang; Tiffany J Petrisko; Ahmad Alhowail; Sharay E Setti; Vishnu Suppiramaniam; Gregory W Konat; Miranda N Reed
Journal:  J Neurochem       Date:  2016-06-03       Impact factor: 5.372

8.  Role for complement in the development of seizures following acute viral infection.

Authors:  Jane E Libbey; Nikki J Kirkman; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

9.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

10.  Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures.

Authors:  Sarah Jamali; Annick Salzmann; Nader Perroud; Magali Ponsole-Lenfant; Jennifer Cillario; Patrice Roll; Nathalie Roeckel-Trevisiol; Ariel Crespel; Jorg Balzar; Kurt Schlachter; Ursula Gruber-Sedlmayr; Ekaterina Pataraia; Christoph Baumgartner; Alexander Zimprich; Fritz Zimprich; Alain Malafosse; Pierre Szepetowski
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.